Stock comparison

JNJvsV

Johnson & Johnson vs Visa Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE

Visa Inc

$317.02

-8.86%

Financial Services$584.8BNYSE

60-day price, rebased to 100

JNJ +7.18% · V -3.05%

Round-by-round

JNJ 2·V 3· 1 tie

EdgeJNJ

Valuation upside

-49.50% vs -65.20% to DCF fair value

EdgeV

Balance-sheet strength

Altman Z 5.48 vs 10.64

EdgeV

Fundamental quality

Piotroski 4.00 vs 7.00 (of 9)

EdgeV

Growth + margins

Rule-of-40 -5.70 vs 11.50

EdgeJNJ

60-day momentum

+7.18% vs -3.05% price return

Tie

Market-cap liquidity

$585.7B vs $584.8B

Verdict

Across 6 categories, V takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or V

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.